NDC 70594-117-01 - Bupivacaine HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-117
- Requested NDC
- 70594-117-01
- Package NDCs from labels
- 70594-117-01, 70594-117-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC
- Effective date
- 2023-06-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupivacaine HCl - Xellia Pharmaceuticals USA LLC | Xellia Pharmaceuticals USA LLC | 2023-06-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70594-117-01 | Bupivacaine HCl | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 2 | |
| 70594-117-02 | Bupivacaine HCl | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70594-117 | BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION BUPIVACINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [XELLIA PHARMACEUTICALS USA LLC] | 2 | Current NDC, 2 package rows | 20230622_f29c905e-9a55-446f-a89d-860ad9ade7ad.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-117-01 | ML - Milliliter | 70594-117 | 2feb9562-35c1-4637-931e-9f2fbd531c6a | 1 | 2023-08-08 |
| 70594-117-02 | ML - Milliliter | 70594-117 | 76e4c81c-6b22-4365-85ea-1c7bc2ea9661 | 1 | 2023-08-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupivacaine Hydrochloride with Dextrose | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | B. Braun Medical Inc. | ff43d2b6-acb4-45c8-96b6-971d2a7a6767 | 2024-11-05 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | eb6d8fee-def4-4c96-9972-695e8cea8ea8 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1725078 1725082 7TQO7W3VT8 |
| Dyural 80-LM | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | c4071146-7d89-4c3a-9278-389d801cf66d | 2024-10-05 | Boxed warning, Warnings, Adverse reactions | 1725078 1725082 |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 950d82b6-76a1-0c08-e053-2a95a90a3a92 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine hydrochloride | BUPIVACAINE HYDROCHLORIDE | Somerset Therapeutics, LLC | bcaab86f-20f0-4482-8d73-e29b36dced58 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | A-S Medication Solutions | 1091d4d8-5dad-46e1-8f26-7bc0c5dd833f | 2024-05-31 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 8815c8c6-eed8-4afe-a5c1-44d2194025a3 | 2024-04-11 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1724787 1725078 1725082 1724786 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 4595c642-1869-436c-9550-8f9f255efd27 | 2024-04-11 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| BUPIVACAINE HCI AND EPINEPHRINE | BUPIVACAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 99516811-56e2-9c8a-e053-2a95a90ac9cb | 2024-01-30 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 946ce625-3647-5083-e053-2a95a90a1ebc | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| BUPIVACAINE HCI | BUPIVACAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | e37e1599-db88-2fcd-e053-2995a90a00e5 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| BUPIVACAINE HYDROCHLORIDE injection, solution | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION | HF Acquisition Co LLC, DBA HealthFirst | 06c15208-c600-7173-e063-6394a90a2f94 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | f37a19ad-5e69-44a8-947b-847df2106fb3 | 2023-08-10 | Boxed warning, Warnings, Adverse reactions | 1724880 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | 8759cac8-d977-4c2a-814c-5b59f2f0c910 | 2023-08-09 | Boxed warning, Warnings, Adverse reactions | 1724880 7TQO7W3VT8 |
| Marvona SUIK | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | f03f28d9-e42e-404d-9c9c-7707aedb478c | 2023-07-19 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| bupivacaine hydrochloride | BUPIVACAINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc | fe340f98-a0f3-446e-b281-47fd91c1e537 | 2023-06-23 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine HCl | BUPIVACAINE HYDROCHLORIDE | Xellia Pharmaceuticals USA LLC | 3335dabe-66d5-440b-a59a-b62993030e0f | 2023-06-09 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine HCl | BUPIVACAINE HYDROCHLORIDE | Xellia Pharmaceuticals USA LLC | f29c905e-9a55-446f-a89d-860ad9ade7ad | 2023-06-09 | Boxed warning, Warnings, Adverse reactions | ANDA091487 70594-118-01 70594-114-02 70594-114-01 70594-115-01 70594-120-01 70594-117-02 70594-117-01 70594-121-01 70594-120-02 70594-121 70594-114 70594-115 70594-120 70594-118 70594-117 70594011701 1724880 1724884 1724787 1725078 1725082 1724786 afc179ac-71b9-4021-8b71-3372bf590e4a f29c905e-9a55-446f-a89d-860ad9ade7ad 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 694926ac-aff0-aa1f-e053-2991aa0a9588 | 2023-05-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.